APGE
Apogee Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$135.07
+0.00%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.08x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 0.34x
Liquidity & coverage
- Current ratio
- 26.44x
- Quick ratio
- 26.44x
- Cash ratio
- 25.91x
- Interest coverage
- -207.66x
- EBITDA / interest
- -184.37x
- Working capital
- $954.2M
Cash & dividend
- FCF / debt
- -35.70x
- Cash flow / debt
- -35.69x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026